Orchid Pharma Ltd

Orchid Pharma Ltd

Orchid Pharma Ltd has informed that its Board of Directors has approved the issuance and allotment of 4,45,86,052 fully paid-up equity shares to eligible shareholders of Dhanuka Laboratories Ltd as part of the scheme of amalgamation. The shares will be listed and traded on BSE and NSE and will rank pari-passu with existing equity shares.

Orchid Pharma Ltd

Orchid Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2026, inter alia, to consider and approve prior intimation of board meeting.

Orchid Pharma Ltd

Orchid Pharma Ltd has announced an Investor Roadshow scheduled to be held in Singapore on July 29-31, 2026. The event will be attended by Mr. Mridul Dhanuka, Whole Time Director of the Company. No unpublished price sensitive information will be shared during the meet.